Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Anixa Biosciences, Inc. ANIX

Full chart Compare

Set alert

3.06 USD -0.10 (-3.16%)

At closeNov 10, 2026, 4:00 PM EST

2.95 -0.11 -3.59%

After hours · Nov 10, 4:00 PM ET

3.04 Day range 3.18

2.32 52-week range 5.46

YTD: -1.92%
1 year: -26.97%

News

6 days ago prnewswire.com Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Immuno-Oncology & Advanced Therapies Congress 2026 Dr. Robert Wenham, principal investigator of Anixa's Phase 1 clinical trial at Moffitt Cancer Center, to present on December 14 in London SAN JOSE, Calif., Nov. 4, 2026 /PRNewswire/ -- Anixa…
2 weeks ago benzinga.com Anixa Biosciences Completes Dosing Of Fifth Group In Its Phase 1 Clinical Study Of FSHR-Targeted CAR-T Therapy To Treat Ovarian Cancer Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has completed dosing of the fifth